Updated 02:01 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,868.50 -0.46% CL 85.14 -3.86% BTC 65,305.22 0.00%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,869 −0.46% BTC $65,305 VIX 22.91 +18.70% latest tape · as of 02:01 UTC
The Screen · Energy · Oil & Gas Midstream

DT Midstream Inc

DTM · the NYSE · USD · Market cap $11.6B · 588 employees

DT Midstream, Inc., together with its subsidiaries, provides integrated natural gas services in the United States.

FAIL · Does not pass the screen
119.73 USD

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price119.73 USD at the 13 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.03)
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $93.73 to $107.79, base estimate $93.73 (screen dated 2026-11-13).

Current read
Markup ?
Overvalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.03, read 2026-11-14
  • Ethical does not pass the values gate
Price119.73 USD
Fair value93.73
Ethical score70.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-21Read Distribution126.55-5.4% to today ✓Markdown gives way to Distribution
2026-10-02Read Markdown125.05-4.3% to today ✓Distribution gives way to Markdown after a 7% slide in 5 weeks
2026-08-27Read Distribution134.79-11.2% to today ✓Markdown gives way to Distribution after a 5% slide in 8 weeks
2026-07-02Read Markdown142.32-15.9% to today ✓First review on file: Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

DT Midstream Inc holds its Markup at $119.73. The statistical read favours the sellers, held for 358 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 358 days
Price at the screen$119.73
Valuation24.76 trailing · 22.62 forward price to earnings
Values screenFAIL · score 70.0
Beta0.74
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 33.45% Below 33% Interest-bearing debt is 33.5% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 2.38% Below 49% Money owed to the company is 2.4% of assets, under the 49% limit. Pass
Revenue purity 0.16% Below 5% Only 0.2% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

DT Midstream's business is in a permissible area, but its interest-bearing debt is about 33% of the company, just over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when DTM's ethical verdict changes

Today DTM does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $93.73 fair value estimate, narrow competitive moat, 7.00% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

93.73Conservative93.73Base case107.79Growth case 119.73Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 27.7% above the base estimate.

The Street's Range
121.00Street low 145.00Street average 170.00Street high 119.73Price

Third-party analyst targets: 15 covering, consensus Buy. The average target sits +21% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections

Where our models see it going: fair-value estimate $93.73, with a range of $93.73 to $107.79, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Gas Pipelines Priced Well Beyond Fair Value

Picture the vast web of pipes carrying gas from wells to power plants and homes. DT Midstream sits in the middle of that flow, yet it trades at 145 dollars against a fair value near 99, a 32 percent premium that leaves little room for error.

The numbers do not support stretching for it. Forward earnings sit at 29 times, revenue rises at 11 percent, yet return on equity reaches only 10 percent behind a narrow moat. In a cyclical energy sector that pattern often signals peak conditions rather than a bargain, and the opportunity rating stays at none.

Energy volumes can swing sharply with weather, prices and policy. A narrow competitive edge offers limited defence when those cycles turn. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E22.6xexpensive even after accounting for its growth
Trailing P/E24.8xa premium valuation
EPS, trailing4.59
EPS, forward5.03
Revenue growth+7.0%slow but positive growth
Profit margin35.4%highly profitable on every dollar of sales
Return on equity9.9%a modest return on shareholder capital
FCF yield2.27%
Dividend yield2.46%
Debt to equity0.67moderate, manageable leverage
Current ratio1.16adequate liquidity, worth monitoring
Beta0.74steadier than the market
Short interest, float0.09%
52-week range111.01 - 152.88
MoatNARROW
Market cap$11.6B
Employees588

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

DTM trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-12 Distribution $119.00 +1.2% Entry 18

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154.

2026-11-05 Distribution $117.58 -5.1% Entry 17

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154.

2026-10-29 Distribution $123.91 +0.0% Entry 16

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-28 Distribution $123.91 +0.0% Entry 15

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Distribution $123.91 +0.0% Entry 14

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Distribution $123.91 +0.0% Entry 13

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Distribution $123.91 +0.0% Entry 12

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Distribution $123.91 -2.1% Entry 11

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Distribution $126.55 +0.0% Entry 10

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-22 Distribution $126.55 +0.0% Entry 9

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on DTM

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in DTM's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $145.30 -2.3% · $977 -2.3%
2 months $135.64 +4.6% · $1,046 +4.6%
3 months $134.77 +5.3% $0.88 $1,060 +6.0%
6 months $117.95 +20.3% $1.70 $1,218 +21.8%
1 year $101.48 +39.9% $3.34 $1,432 +43.2%
2 years $64.59 +119.8% $6.37 $2,296 +129.6%
3 years $43.40 +227.1% $9.17 $3,482 +248.2%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever DTM does next, these words stay.

DT Midstream Inc · DTM · Markup · $119.73
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.